Today in News History
On July 12, several notable moments in the history of News stand out. In 1923, James E. Gunn, American science fiction author (died 2020) was born. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1943, Paul Silas, American basketball player and coach (died 2022) was born. In 1948, Richard Simmons, American fitness trainer and actor (died 2024) was born. In 1985, Keven Lacombe, Canadian cyclist was born. In 1995, Jordyn Wieber, American gymnast was born. In 1996, Jordan Romero, American mountaineer was born. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. In 2006, The 2006 Lebanon War begins. Together, these milestones provide historical context for today's news news and ongoing narratives.
Demand for GLP-1 weight-loss and diabetes drugs plateaus, says industry tracker
A total of 31 generic semaglutide brands contributed to 82 per cent of the unit sales of the month
Narrative Intelligence Brief
This article was published by The Hindu BusinessLine, a source frequently categorized with a lean right bias based in India. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The Hindu BusinessLine, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from The Hindu BusinessLine
July 12, 2026
Employee headcount shrinks at HUL, Dabur amid hike in median pay in FY26
July 12, 2026
NCLAT allows withdrawal of insolvency case against Oswal Overseas after settlement with creditor
July 12, 2026
Two-wheelers present bigger challenge for Delhi EV policy: Crisil Ratings
July 12, 2026
SIF AUM jumps 29% to ₹17,858 crore in June; hybrid strategies hold 72% share
July 12, 2026
Indian Bank aims to recover ₹5,500 from bad loans during FY27: MD Binod Kumar
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"argentina"
Maxi Rodríguez se rinde ante Mikel Merino por su gran actuación con España | Hoy en el Mundial
Argentina Women’s Youth National Team Coach Accused of Sexual Harassment
Argentina's Antonio Rattín Dies; 1966 World Cup Dismissal Led To Red & Yellow Cards
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 67%
Center 17%
Right 17%
Knewz
· Jul 6, 2026
Comprehensive guide on weight loss using GLP-1 medications: Here’s a detailed list!
Glucagon-like peptide-1 (GLP-1) therapies have offered clinically proven weight-loss and metabolic benefits. We know that obesity is a relapsing and chronic ailment that has affected more than 1 billion individuals across the world. Hence, knowing what to do makes all the difference. What are GLP-1 agonists in brief? These are classes of medicines that are usually...
The Hill
· Jul 7, 2026
GLP-1 use reaches record high as access appears easier
Click in for more news from The Hill {beacon} Healthcare Health Care The Big Story GLP-1 use reaches record high as access appears easier New data released this week found that a record number of Americans are taking a GLP-1 medication for weight loss. © AP Photo/David J. Phillip According to a new Gallup...
Foreign Policy Journal
· Jul 9, 2026
GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds
A new Gallup survey reveals that 11 of U.S. adults currently take GLP-1 medications for weight loss, a sharp rise from just 3 in 2024. The figure climbed steadily, moving from 3 in 2024 to 8 in 2025, before reaching the current 11 recorded in the latest survey conducted in mid-2026. Gallup also found that [] The post GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds appeared first on Foreign Policy Journal.
Kaiser Health
· Jun 26, 2026
Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know
If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.
Boston.com
· Jun 28, 2026
MassHealth will stop covering weight-loss drugs next week
The change will leave an estimated 22,000 MassHealth members on the hook to pay out of pocket for the pricy GLP-1s and other anti-obesity drugs. The post MassHealth will stop covering weight-loss drugs next week appeared first on Boston.com.
Gizmodo
· Jul 8, 2026
11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy
15 of Americans have ever taken the drugs, up from 6 in 2024.
Topics:
Related coverage for "Demand for GLP-1 weight-loss and diabetes drugs plateaus, says industry tracker": Knewz — Comprehensive guide on weight loss using GLP-1 medications: Here’s a detailed list!. The Hill — GLP-1 use reaches record high as access appears easier . Foreign Policy Journal — GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds. Kaiser Health — Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know. Boston.com — MassHealth will stop covering weight-loss drugs next week. Gizmodo — 11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy